Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1830 (LINC01830)
- Target
- LINC01830
- Molecular classification
- Long non-coding RNA, Long intergenic non-coding RNA (lincRNA)
01
Overview
Long intergenic non-protein coding RNA 1830 (LINC01830) is a member of the lincRNA family, which comprises RNA transcripts longer than 200 nucleotides, with no protein-coding potential and located away from annotated coding genes[3][7]. The biological significance of lincRNAs generally arises from their roles in chromatin remodelling, transcriptional regulation, or the regulation of neighbouring genes, often displaying tissue-specific expression and diverse, context-dependent functions[1][3][5][7]. As of the current date, no published data describe the specific biological functions, disease associations, or drug interactions of LINC01830.
- Other names
- LOC124908056LINC01830
02
Mechanism of action
None known. No drugs target LINC01830, and no mechanism of action has been described
03
Biological functions
Chromatin remodellingRegulation of gene expressionRNA stabilizationPossibly enhancer-associated activityModulation of transcription
04
Disease associations
Other (No disease associations specifically related to LINC01830 have been identified; an extensive literature search yields no functional or clinical studies for LINC01830.)
05
Safety considerations
None known. There are no reports of safety concerns or therapeutic challenges related to manipulation or targeting of LINC01830
06
Interacting drugs
None known. There is no evidence of any drug interacting with LINC01830
07
Biomarkers
None known. LINC01830 has not been identified as a biomarker for patient selection or any monitoring purpose
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 1830 (LINC01830).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1830 (LINC01830).